Prestige Consumer Healthcare (PBH) Current Leases (2019 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Current Leases of $2.6 million for Q4 2025, down 56.56% year-over-year from $6.0 million in Q4 2024, and up 1.63% quarter-over-quarter from $2.6 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Current Leases (2019 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Current Leases history runs 7 years deep, the most recent figure standing at $2.6 million for Q4 2025.
- In Q4 2025, Current Leases fell 56.56% year-over-year to $2.6 million; the TTM figure through Dec 2025 stood at $2.6 million (down 56.56% YoY), while the FY2025 annual figure was $6.0 million, up 29.82% from the prior year.
- Current Leases for Q4 2025 stood at $2.6 million, up from $2.6 million in the prior quarter.
- The five-year high for Current Leases was $6.9 million in Q4 2022, with the low at $91000.0 in Q3 2024.
- The 5-year median for Current Leases is $3.3 million (2023), against an average of $4.1 million.
- The sharpest annual moves came in 2024 and 2025: Current Leases slumped 98.65% in 2024, then jumped 2726.37% in 2025.
- Prestige Consumer Healthcare's Current Leases stood at $2.6 million in 2021, then soared by 159.18% to $6.9 million in 2022, then slipped by 17.61% to $5.6 million in 2023, then increased by 6.51% to $6.0 million in 2024, then slumped by 56.56% to $2.6 million in 2025.
- Business Quant data shows PBH's Current Leases at $2.6 million in Q4 2025, $2.6 million in Q3 2025, and $2.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - | 6.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.91 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 2.57 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Mar 31, 2025 | 6.05 Mn |
| Dec 31, 2024 | 6.02 Mn |
| Sep 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 3.65 Mn |
| Mar 31, 2024 | 4.66 Mn |
| Dec 31, 2023 | 5.65 Mn |
| Sep 30, 2023 | 6.73 Mn |
| Jun 30, 2023 | 2.86 Mn |
| Mar 31, 2023 | 2.83 Mn |
| Dec 31, 2022 | 6.86 Mn |
| Sep 30, 2022 | 2.79 Mn |
| Jun 30, 2022 | 6.55 Mn |
| Mar 31, 2022 | 2.75 Mn |
| Dec 31, 2021 | 2.65 Mn |
| Sep 30, 2021 | 2.63 Mn |
| Jun 30, 2021 | 5.97 Mn |